-
Mashup Score: 2Radiation Plus Combination Immunotherapy May Help Preserve Bladder in Some Patients With Muscle-invasive Bladder Cancer - 4 day(s) ago
Radiation plus immunotherapy may help some patients with invasive bladder cancer keep their bladders, according to a study published in Clinical Cancer Research.
Source: www.aacr.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants - 4 day(s) ago
$50,000 over one year for researchers that seek to stimulate creative approaches to translate basic research into new treatment options for kidney cancer.
Source: www.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
The AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants are one-year, $50,000 grants to stimulate creative approaches to translate basic research into new treatment options for kidney cancer. Apply by February 18. Learn more: https://t.co/mXQd57ci3p https://t.co/dZlmadnofN
-
-
Mashup Score: 4Adding Immunotherapy to Neoadjuvant Chemoradiation May Improve Outcomes in Esophageal Cancer - 4 day(s) ago
Combination of radiation, chemotherapy, and immunotherapy can shrink tumors and allow surgery, with much better survival rate rather than with non-surgical treatment alone
Source: www.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
The combination of immunotherapy, chemotherapy, and radiation can shrink locally advanced esophageal tumors and improve patients’ odds of successful surgery and survival, according to a study published in @CCR_AACR: https://t.co/qT2ee9YDrc https://t.co/NUbreDvE4W
-
-
Mashup Score: 3Leading Discoveries Magazine - 8 day(s) ago
A Publication of the American Association for Cancer Research
Source: leadingdiscoveries.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
The new issue of Leading Discoveries magazine is online, with articles on @DrRobWinn and advances against cancer disparities, the upcoming AACR immuno-oncology meeting, and much more. https://t.co/YbW1mt5drF https://t.co/AxkfmeD1MB
-
-
Mashup Score: 2Program: Wednesday, February 26 - 8 day(s) ago
wednesday, february 26 continental breakfast 7-8 a.m. | Platinum Ballroom F-J Keynote Session 4 8-8:30 a.m. | Diamond Ballroom 4-5 Session Chair: Antoni Ribas, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California education sessions 5 and 6 8:40-10 a.m. Educational Session 5: Multi-specific Antibodies and Antibody Fusion Proteins Diamond Ballroom 4-5 Session Chair: Avery D. […]
Source: www.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
Multi-Specific Antibodies and Antibody Fusion Proteins: Pablo Umaña, Avery Posey, & Jamie @SpanglerLab will address this topic in a session at the #AACRIO25 Conference on Discovery and Innovation in Cancer Immunology (Feb 23-26; Los Angeles). https://t.co/vNiRLp2v6j @IAmDrDex https://t.co/pCYCrle3RC
-
-
Mashup Score: 22025 AACR Runners for Research 5K Run/Walk - 8 day(s) ago
Join AACR members, Annual Meeting attendees, and local runners in Chicago for this signature event. All proceeds support the AACR’s mission.
Source: www.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
Join us Saturday, April 26 in Chicago for the AACR Runners for Research 5K Run/Walk to advance lifesaving cancer research! Learn more and register today: https://t.co/iw2N3SEZSM #AACR25
-
-
Mashup Score: 0Population Sciences Working Group - 8 day(s) ago
The mission of this working group is to foster and strengthen team-based, trans-disciplinary research to develop a more integrated understanding of cancer etiology and outcomes in human populations.
Source: www.aacr.orgCategories: General Medicine News, Onc News and JournalsTweet-
We congratulate Melissa Troester, PhD, the AACR Population Sciences Working Group Chair-elect for 2025-2026. Dr. Troester will assume the office of Chair-elect at the AACR Annual Meeting 2025, April 25-30 in Chicago, Illinois. #AACR25 https://t.co/MwIXi50lSx https://t.co/n6o0bfx8Sp
-
-
Mashup Score: 4AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants - 9 day(s) ago
$50,000 over one year for researchers that seek to stimulate creative approaches to translate basic research into new treatment options for kidney cancer.
Source: www.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
The AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants are one-year, $50,000 grants to stimulate creative approaches to translate basic research into new treatment options for kidney cancer. Apply by February 18. Learn more: https://t.co/i0eyrft4S6 https://t.co/X1JWbfVsdu
-
-
Mashup Score: 7
Four recipients of the Global Scholar-in-Training Award (GSITA) share how their experience at the AACR Annual Meeting impacted their careers.
Source: www.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
As the recipients of a 2025 AACR Global Scholar-in-Training Award prepare to attend #AACR25, four past recipients reflect on how the experience has impacted their careers. Learn more on the #AACRBlog: https://t.co/uRMXjvJXtB #AACRGlobalScholars @CSIR @usponline @UnivofDelhi https://t.co/f5O4jt3PPa
-
-
Mashup Score: 7
On February 11, 2025, the Food and Drug Administration approved mirdametinib (Gomekli, SpringWorks Therapeutics, Inc.), a kinase inhibitor, for adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet-
The @US_FDA approved the kinase inhibitor mirdametinib for adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas: https://t.co/eIfcOuJh8O
-
Radiation plus a combination of immune checkpoint inhibitors may help some patients with muscle-invasive bladder cancer avoid the removal of their bladders, according to a study published in @CCR_AACR. Learn more: https://t.co/LYyj4xRei3 https://t.co/vjPByRMaNm